CVC Capital Partners falls 7% despite record realisations

CVC reported adjusted profit after tax of €873m for year-ended Dec 31, 2025, narrowly ahead of the €867m analyst consensus, with EPS €0.79 (+5% YoY). The firm recorded €21.9bn of private equity realisations (+67% YoY) delivering a 3.2x gross multiple and 23% gross IRR, while fee-paying AUM was €148bn (+1% YoY). Management guided performance-related earnings of €600-700m for 2026-27, rising to €1.2-1.5bn by 2028-29; announced total 2025 dividend €0.47/share (+11%) and a €350m buyback (€75m initial). Shares fell ~7.1% on the mixed outlook despite strong exit returns and capital returns actions.

Analysis

Large private markets realizations create an outsized short-term distortion between headline earnings and the recurring fee stream that investors value — the market is pricing a cliff in near-term economics rather than a multi-year cadence. That disconnect amplifies volatility in listed GPs: distributions reduce fee-bearing capital today even as they seed fundraising and performance fees over the next 2-5 years, creating a timing mismatch between cash flows and sentiment.

Secondary effects matter more than headline numbers. Accelerated exit activity widens opportunity for secondary buyers, strengthens placement agents and raises redeployment risk for banks underwriting new deals; conversely, managers with secular fee growth in credit and infrastructure will see disproportionate benefit if public markets re-rate recurring revenue higher over 12-24 months.

Key catalysts to watch are the pace of new fund closes, carry crystallization cadence, and the cadence of share capital returns from boards. Near-term price moves will hinge on quarterly guidance and tranche timing; medium-term direction depends on demonstrable AUM restoration and visible carry accrual over the next 18-36 months. Macro shocks or a tougher exit multiple backdrop could reverse any re-rating quickly.

The consensus is fixated on the quarter-to-quarter headline rather than the multi-year optionality of redeployment and fee mix shift. That opens asymmetric opportunities: either buy the mispriced multi-year carry ramp into fundraises and fee mix improvement, or short managers whose earnings are most exposed to transient AUM declines and slow redeployment.

Key Decisions for Investors

• Long CVC (AS:CVC) — size 2-3% NAV, 6-12 month horizon. Entry on >5% follow-through weakness; target +30% total return if fundraising and carry ramp materialize, stop -18% on missed guidance or delayed fund closes.
• Pair trade: Long BX (Blackstone) or KKR (KKR) vs Short CVC (AS:CVC) 1:1 — 12-24 month horizon. Rationale: overweight recurring-fee heavy managers vs names with near-term AUM sensitivity. Seek asymmetric upside (~25%) with relative stop at 12% move against the pair.
• Long Hamilton Lane (HL) or listed secondaries exposure — 6-18 month horizon. Buy on pullback of ~8-10%; target +20% if secondary pricing remains robust and fundraising accelerates; stop 15%.
• Tactical options: Buy 9-12 month out-of-the-money calls on a chosen PE manager (e.g., AS:CVC) sized at 1% NAV to capture re-rating with defined downside. Alternatively sell near-term puts if willing to accumulate equity at a net lower cost, but cap allocation to avoid forced capital deployment into a softer fundraising cycle.